Nam Kim Steel JSC (HOSE:NKG)
Vietnam · Delayed Price · Currency is VND 15,500
-650 (-4.02%)
At close: Aug 1, 2025
Sage Therapeutics Income Statement
Financials in millions VND. Fiscal year is January - December.
Millions VND. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
| 17,556,038 | 20,609,022 | 18,595,974 | 23,071,247 | 28,173,402 | 11,559,675 | Upgrade | |
Revenue Growth (YoY) | -10.76% | 10.82% | -19.40% | -18.11% | 143.72% | -5.07% | Upgrade |
Cost of Revenue | 16,270,269 | 18,777,248 | 17,483,711 | 21,589,887 | 23,903,545 | 10,690,465 | Upgrade |
Gross Profit | 1,285,768 | 1,831,774 | 1,112,263 | 1,481,361 | 4,269,857 | 869,210 | Upgrade |
Selling, General & Admin | 866,750 | 1,137,840 | 739,414 | 1,388,107 | 1,520,672 | 359,857 | Upgrade |
Operating Expenses | 866,750 | 1,137,840 | 739,414 | 1,388,107 | 1,520,672 | 359,857 | Upgrade |
Operating Income | 419,018 | 693,934 | 372,849 | 93,253 | 2,749,185 | 509,353 | Upgrade |
Interest Expense | -232,413 | -207,841 | -292,680 | -262,466 | -182,427 | -222,154 | Upgrade |
Interest & Investment Income | 28,352 | 28,352 | 18,761 | 28,836 | 15,154 | 27,091 | Upgrade |
Currency Exchange Gain (Loss) | 42,517 | 42,517 | 77,004 | 33,044 | 30,261 | 887.25 | Upgrade |
Other Non Operating Income (Expenses) | 33,652 | 1,209 | 1,376 | 419.66 | -50,145 | 5,636 | Upgrade |
EBT Excluding Unusual Items | 291,126 | 558,170 | 177,311 | -106,913 | 2,562,029 | 320,812 | Upgrade |
Pretax Income | 291,126 | 558,170 | 177,311 | -106,913 | 2,562,029 | 320,812 | Upgrade |
Income Tax Expense | 50,864 | 105,162 | 59,902 | 17,772 | 336,768 | 25,543 | Upgrade |
Earnings From Continuing Operations | 240,262 | 453,008 | 117,409 | -124,685 | 2,225,261 | 295,270 | Upgrade |
Net Income | 240,262 | 453,008 | 117,409 | -124,685 | 2,225,261 | 295,270 | Upgrade |
Preferred Dividends & Other Adjustments | - | - | 4,696 | - | 69,470 | 8,858 | Upgrade |
Net Income to Common | 240,262 | 453,008 | 112,712 | -124,685 | 2,155,791 | 286,411 | Upgrade |
Net Income Growth | -40.09% | 285.84% | - | - | 653.64% | 523.80% | Upgrade |
Shares Outstanding (Basic) | - | 316 | 316 | 316 | 306 | 307 | Upgrade |
Shares Outstanding (Diluted) | - | 316 | 316 | 316 | 306 | 307 | Upgrade |
Shares Change (YoY) | - | - | 0.02% | 3.20% | -0.18% | -2.50% | Upgrade |
EPS (Basic) | - | 1433.88 | 356.76 | -394.73 | 7043.42 | 934.10 | Upgrade |
EPS (Diluted) | - | 1433.88 | 356.76 | -395.00 | 7043.33 | 934.03 | Upgrade |
EPS Growth | - | 301.92% | - | - | 654.08% | 540.48% | Upgrade |
Free Cash Flow | -2,497,327 | -1,444,393 | 138,326 | -1,039,081 | -453,340 | -38,697 | Upgrade |
Free Cash Flow Per Share | - | -4571.85 | 437.83 | -3289.58 | -1481.16 | -126.20 | Upgrade |
Dividend Per Share | - | - | - | - | 694.444 | 173.611 | Upgrade |
Dividend Growth | - | - | - | - | 300.00% | - | Upgrade |
Gross Margin | 7.32% | 8.89% | 5.98% | 6.42% | 15.16% | 7.52% | Upgrade |
Operating Margin | 2.39% | 3.37% | 2.00% | 0.40% | 9.76% | 4.41% | Upgrade |
Profit Margin | 1.37% | 2.20% | 0.61% | -0.54% | 7.65% | 2.48% | Upgrade |
Free Cash Flow Margin | -14.22% | -7.01% | 0.74% | -4.50% | -1.61% | -0.34% | Upgrade |
EBITDA | 779,928 | 1,062,612 | 748,676 | 471,033 | 3,128,019 | 885,608 | Upgrade |
EBITDA Margin | 4.44% | 5.16% | 4.03% | 2.04% | 11.10% | 7.66% | Upgrade |
D&A For EBITDA | 360,910 | 368,678 | 375,827 | 377,779 | 378,834 | 376,256 | Upgrade |
EBIT | 419,018 | 693,934 | 372,849 | 93,253 | 2,749,185 | 509,353 | Upgrade |
EBIT Margin | 2.39% | 3.37% | 2.00% | 0.40% | 9.76% | 4.41% | Upgrade |
Effective Tax Rate | 17.47% | 18.84% | 33.78% | - | 13.15% | 7.96% | Upgrade |
Revenue as Reported | 17,556,038 | 20,609,022 | 18,595,974 | 23,071,247 | 28,173,402 | 11,559,675 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.